114 related articles for article (PubMed ID: 20635925)
1. Immunotherapy with oral, heat-killed, Mycobacterium vaccae in patients with moderate to advanced pulmonary tuberculosis.
Dlugovitzky D; Notario R; Martinel-Lamas D; Fiorenza G; Farroni M; Bogue C; Stanford C; Stanford J
Immunotherapy; 2010 Mar; 2(2):159-69. PubMed ID: 20635925
[TBL] [Abstract][Full Text] [Related]
2. A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma.
O'Brien ME; Saini A; Smith IE; Webb A; Gregory K; Mendes R; Ryan C; Priest K; Bromelow KV; Palmer RD; Tuckwell N; Kennard DA; Souberbielle BE
Br J Cancer; 2000 Oct; 83(7):853-7. PubMed ID: 10970684
[TBL] [Abstract][Full Text] [Related]
3. Does immunotherapy with heat-killed Mycobacterium vaccae offer hope for the treatment of multi-drug-resistant pulmonary tuberculosis?
Stanford JL; Stanford CA; Grange JM; Lan NN; Etemadi A
Respir Med; 2001 Jun; 95(6):444-7. PubMed ID: 11421500
[TBL] [Abstract][Full Text] [Related]
4. [The immunotherapeutic effect of Mycobacterium vaccae vaccine on initially treated pulmonary tuberculosis].
Luo Y;
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jan; 24(1):43-7. PubMed ID: 11802939
[TBL] [Abstract][Full Text] [Related]
5. Potential for immunotherapy with heat-killed Mycobacterium vaccae in respiratory medicine.
Stanford J; Stanford C; Dlugovitzky D; Fiorenza G; Martinel-Lamas D; Selenscig D; Bogue C
Immunotherapy; 2009 Nov; 1(6):933-47. PubMed ID: 20635912
[TBL] [Abstract][Full Text] [Related]
6. [A clinical study on vaccine of Mycobacterium vaccae in treating pulmonary tuberculosis].
Wang W; Jin G; Ye Y; Xia X; Wang A; Zhuang Y; Li G; Sun H; Wang Z; Lin M; Chen H; Li J; Dan Z; Zhang X
Zhonghua Jie He He Hu Xi Za Zhi; 1999 Feb; 22(2):108-10. PubMed ID: 11820954
[TBL] [Abstract][Full Text] [Related]
7. Immunological basis for the introduction of immunotherapy with Mycobacterium vaccae into the routine treatment of TB.
Dlugovitzky D; Stanford C; Stanford J
Immunotherapy; 2011 Apr; 3(4):557-68. PubMed ID: 21463195
[TBL] [Abstract][Full Text] [Related]
8. Immunological consequences of three doses of heat-killed Mycobacterium vaccae in the immunotherapy of tuberculosis.
Dlugovitzky D; Fiorenza G; Farroni M; Bogue C; Stanford C; Stanford J
Respir Med; 2006 Jun; 100(6):1079-87. PubMed ID: 16278080
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis.
Stanford J; Stanford C; Grange J
Front Biosci; 2004 May; 9():1701-19. PubMed ID: 14977580
[TBL] [Abstract][Full Text] [Related]
10. Orally administered Mycobacterium vaccae modulates expression of immunoregulatory molecules in BALB/c mice with pulmonary tuberculosis.
Hernández-Pando R; Aguilar D; Orozco H; Cortez Y; Brunet LR; Rook GA
Clin Vaccine Immunol; 2008 Nov; 15(11):1730-6. PubMed ID: 18827195
[TBL] [Abstract][Full Text] [Related]
11. Randomized, placebo-controlled Phase II trial of heat-killed Mycobacterium vaccae (Immodulon batch) formulated as an oral pill (V7).
Butov DA; Efremenko YV; Prihoda ND; Zaitzeva SI; Yurchenko LV; Sokolenko NI; Butova TS; Stepanenko AL; Kutsyna GA; Jirathitikal V; Bourinbaiar AS
Immunotherapy; 2013 Oct; 5(10):1047-54. PubMed ID: 24088075
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trial of Mycobacterium vaccae immunotherapy in non-human immunodeficiency virus-infected ugandan adults with newly diagnosed pulmonary tuberculosis. The Uganda-Case Western Reserve University Research Collaboration.
Johnson JL; Kamya RM; Okwera A; Loughlin AM; Nyole S; Hom DL; Wallis RS; Hirsch CS; Wolski K; Foulds J; Mugerwa RD; Ellner JJ
J Infect Dis; 2000 Apr; 181(4):1304-12. PubMed ID: 10753731
[TBL] [Abstract][Full Text] [Related]
13. Improvement in psoriasis after intradermal administration of heat-killed Mycobacterium vaccae.
Balagon MV; Walsh DS; Tan PL; Cellona RV; Abalos RM; Tan EV; Fajardo TT; Watson JD; Walsh GP
Int J Dermatol; 2000 Jan; 39(1):51-8. PubMed ID: 10651968
[TBL] [Abstract][Full Text] [Related]
14. A randomized, blinded, parallel group, placebo controlled pilot study evaluating the effect of PVAC treatment in patients with diffuse systemic sclerosis.
Genovese MC; Chakravarty EF; Boyle DL; Tutuncu Z; Thorburn CM; Halilhodzic M; Kroll S; Baughman J; Stewart S; Kavanaugh A
J Rheumatol; 2005 Dec; 32(12):2345-50. PubMed ID: 16331761
[TBL] [Abstract][Full Text] [Related]
15. [Immunotherapeutic effect of Mycobacterium vaccae on multi-drug resistant pulmonary tuberculosis].
Luo Y; Lu S; Guo S
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Feb; 23(2):85-8. PubMed ID: 11778496
[TBL] [Abstract][Full Text] [Related]
16. A randomised placebo controlled trial of delipidated, deglycolipidated Mycobacterium vaccae as immunotherapy for psoriatic arthritis.
Dalbeth N; Yeoman S; Dockerty JL; Highton J; Robinson E; Tan PL; Herman D; McQueen FM
Ann Rheum Dis; 2004 Jun; 63(6):718-22. PubMed ID: 15140780
[TBL] [Abstract][Full Text] [Related]
17. Mice with pulmonary tuberculosis treated with Mycobacterium vaccae develop strikingly enhanced recall gamma interferon responses to M. vaccae cell wall skeleton.
Rodríguez-Güell E; Agustí G; Corominas M; Cardona PJ; Luquin M; Julián E
Clin Vaccine Immunol; 2008 May; 15(5):893-6. PubMed ID: 18337379
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis: a randomised controlled trial. Durban Immunotherapy Trial Group.
Lancet; 1999 Jul; 354(9173):116-9. PubMed ID: 10408487
[TBL] [Abstract][Full Text] [Related]
19. Effect of a Mycobacterium vaccae derivative on paediatric atopic dermatitis: a randomized, controlled trial.
Brothers S; Asher MI; Jaksic M; Stewart AW
Clin Exp Dermatol; 2009 Oct; 34(7):770-5. PubMed ID: 19438539
[TBL] [Abstract][Full Text] [Related]
20. Randomized, placebo-controlled phase II trial of heat-killed Mycobacterium vaccae (Longcom batch) formulated as an oral pill (V7).
Efremenko YV; Butov DA; Prihoda ND; Zaitzeva SI; Yurchenko LV; Sokolenko NI; Butova TS; Stepanenko AL; Kutsyna GA; Jirathitikal V; Bourinbaiar AS
Hum Vaccin Immunother; 2013 Sep; 9(9):1852-6. PubMed ID: 23782489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
